S. K. Larsen

发表

PTD-mediated Loading of Tumor-Seeking Lymphocytes with Prodrug-Activating Enzymes

P. Robbins, P. Basse, Qin Yang, 2008, The AAPS Journal.

Spontaneous presence of FOXO3-specific T cells in cancer patients

I. Svane, Ö. Met, P. Straten, 2014, Oncoimmunology.

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

I. Svane, P. Straten, S. K. Larsen, 2012, Cells.

Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

I. Svane, S. K. Larsen, M. Andersen, 2014, Leukemia.

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

I. Svane, R. Andersen, P. Straten, 2013, Journal of Immunotherapy for Cancer.

Functional characterization of Foxp3-specific spontaneous immune responses

I. Svane, A. Woetmann, N. Odum, 2013, Leukemia.

Cancer Therapy : Clinical Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2 , 3 Dioxygenase

I. Svane, R. Andersen, P. Straten, 2013 .

HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.

M. Donia, I. Svane, T. Klausen, 2013, Cancer research.

Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

I. Svane, R. Andersen, P. thor Straten, 2013, Clinical Cancer Research.

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

J. Becker, I. Svane, Ö. Met, 2015, Oncoimmunology.

NK cells in the tumor microenvironment.

P. Basse, S. K. Larsen, Yanhua Gao, 2014, Critical reviews in oncogenesis.